EXCLUSIVE: Andrew Stanleick Signs Up With Kenvue

Andrew Stanleick has a brand-new gig.

The previous long time Coty executive, who was most just recently president of openly noted BeautyHealth, has actually been called Kenvue Inc.’s president of skin health and appeal in The United States and Canada, Europe, Middle East and Africa.

His remit will consist of brand names like Neutrogena, Aveeno and OGX, in those areas.

” We are extremely delighted to have Andrew sign up with Kenvue in this crucial function,” stated Charmaine England, primary development officer at Kenvue. “With over twenty years of experience in leading the successful development and omnichannel improvement of worldwide multibrand portfolios in skin health, appeal and style, Andrew brings a tested track-record of success and deep market understanding to enhance the development trajectory of our skin health and appeal section in essential markets.”.

Stanleick included: “As an international leader in customer health, Kenvue’s renowned skin health and appeal brand names have actually been relied on by customers and suggested by healthcare experts for generations. I anticipate assisting these brand names reach more customers in brand-new methods 2025 and beyond.”.

Prior to signing up with Kenvue, Stanleick functioned as the president and CEO of BeautyHealth, owner of the Hydrafacial gadget. Before that, he was executive vice president of Coty Americas, supervising their portfolio of high-end and customer brand names throughout the area. He likewise functioned as the worldwide CEO for the joint endeavor with Kylie Jenner Charm and supervise the Kim Kardashian organization.

Previously in his profession, Stanleick invested numerous years as president and CEO of Coach, Europe and South Asia and Pacific.

Kenvue was drawn out of Johnson & & Johnson in May 2023 as its own public entity, concentrated on the customer side of business. In its financial 2nd quarter ended June 30, net sales amounted to $4 billion, down 0.3 percent from the year prior, however above Wall Street expectations. However within that, its skin health organization saw sales drop 4 percent to $1.16 billion.

Most just recently, activist financier group Starboard Worth took a big stake in Kenvue, and zeroed in on how in can enhance its skin care offering, which is comprehended to be worth around $5 billion.

” Kenvue has a strong portfolio of leading customer brand names, however its capacity has actually not been completely understood. There’s a clear chance to enhance profits development and margins in essential sectors like skin health,” Starboard CEO Jeff Smith stated in a discussion at 13D Screen’s Active-Passive Financier Top last month.